Jorge H. V.
- Country
- Spain
- Department
- Neurology
Research Overview
- Evaluation of Lu AF28996 in the Treatment of Parkinson's Disease in Affected Patients
- Evaluation of ARO-ATXN2 Injection in Adult Patients With Spinocerebellar Ataxia Type 2
- Randomized, Double‑Blind, Placebo‑Controlled Phase 3 Trial of Oral Votoplam in Adults with Huntington’s Disease Assessing cUHDRS Progression
Data & Insights
Has run more than one trial at 124 of 244 partner sites.
Specializations
Parkinson's Disease Research
This investigator specializes in neurodegenerative disorders with a primary focus on Parkinson's disease treatment approaches. Their research encompasses both early-stage Parkinson's and advanced motor symptoms.
- Novel therapeutic compounds investigation
- LRRK2-associated Parkinson's disease
- GBA1 gene variants in PD
- Motor fluctuation management
Their work includes evaluation of both oral and subcutaneous treatment delivery methods for managing Parkinson's symptoms.
Multiple System Atrophy Studies
The investigator conducts extensive research in Multiple System Atrophy (MSA), focusing on innovative therapeutic approaches for this progressive neurological condition.
- Disease progression markers
- Novel therapeutic compounds
- Clinical efficacy assessment
- Long-term disease management
Their research encompasses evaluation of various therapeutic interventions aimed at modifying MSA disease progression.
Therapeutic Innovation
The investigator's work centers on experimental therapeutic approaches for neurological disorders, with particular attention to disease-modifying treatments.
- Safety and tolerability assessments
- Long-term treatment outcomes
- Clinical progression monitoring
- Treatment delivery systems
Their research includes evaluation of various administration methods and dosing strategies for neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.